Valuation: Teva Pharmaceutical Industries Limited

Market Cap 41.2B 35.64B 33.28B 30.53B 57.43B 3,922B 58.34B 391B 153B 1,966B 155B 151B 6,498B P/E 2026 *
47.4x
P/E 2027 * 19.4x
Enterprise Value 53.08B 45.92B 42.88B 39.34B 73.98B 5,052B 75.16B 503B 197B 2,532B 199B 195B 8,371B EV / Sales 2026 *
3.2x
EV / Sales 2027 * 2.88x
Free-Float
88.59%
Yield 2026 *
-
Yield 2027 * -
1 day+1.58%
1 week+1.00%
Current month+1.00%
1 month+6.38%
3 months-1.04%
6 months+1.93%
Current year+13.30%
1 week 33.78
Extreme 33.7804
35.77
1 month 29.6
Extreme 29.6001
35.87
Current year 27.93
Extreme 27.93
37.34
1 year 16.26
Extreme 16.2603
37.34
3 years 8.06
Extreme 8.055
37.34
5 years 6.78
Extreme 6.7791
37.34
10 years 6.07
Extreme 6.07
55.39
Manager TitleAgeSince
Chief Executive Officer 57 2022-12-31
Director of Finance/CFO 53 2019-12-21
Chief Operating Officer 52 2024-06-02
Director TitleAgeSince
Director/Board Member 69 2008-12-31
Chairman 78 2017-02-05
Director/Board Member 65 2015-08-31
Date Insider Type Main position Quantity % Market Cap.
8/3/26 Fiscal year

Chief Technology Officer

131,066 0.0113%
8/3/26 Fiscal year

Head of Human Resources

38,481 0.0033%
6/18/26 Sell

Chief Operating Officer

-9,989 0.0009%
Change 5-day change 1-year change 3-year change Capi.($)
+1.58%+1.00%+116.00%+261.55% 41.2B
-0.52%+3.21%+89.52%+127.32% 1,057B
+0.88%+1.13%+49.56%+49.69% 625B
+0.89%-1.95%+24.23%+64.44% 435B
+0.71%+3.87%+49.07%+37.85% 363B
+0.64%-0.49%+33.94%+40.01% 296B
+0.39%-5.83%+8.92%+7.85% 249B
+1.51%+6.69%+42.58%+57.57% 222B
+3.92%-0.46%-5.56%-52.32% 209B
+1.80%+2.30%+11.56%+66.35% 165B
Average +1.18%+0.88%+41.98%+66.03% 366.2B
Weighted average by Cap. +0.67%+1.21%+49.48%+66.85%

Financials

2026 *2027 *
Net sales 16.58B 14.34B 13.39B 12.29B 23.11B 1,578B 23.48B 157B 61.68B 791B 62.27B 60.91B 2,615B 17.3B 14.97B 13.98B 12.82B 24.12B 1,647B 24.5B 164B 64.37B 825B 64.98B 63.56B 2,729B
Net income 1.14B 986M 921M 845M 1.59B 109B 1.61B 10.81B 4.24B 54.4B 4.28B 4.19B 180B 2.34B 2.02B 1.89B 1.73B 3.26B 222B 3.31B 22.15B 8.69B 111B 8.78B 8.58B 369B
Net Debt 11.88B 10.27B 9.59B 8.8B 16.55B 1,130B 16.82B 113B 44.18B 567B 44.6B 43.63B 1,873B 8.61B 7.45B 6.96B 6.38B 12B 820B 12.19B 81.61B 32.03B 411B 32.34B 31.63B 1,358B
Logo Teva Pharmaceutical Industries Limited
Teva Pharmaceutical Industries Ltd is a Israeli-based pharmaceutical company. The Company operates through three segments: North America, Europe and International Markets. Each business segment manages entire product portfolio in its region, including generics, specialty and over-the-counter (OTC) products. In addition to these three segments, The Company has other activities, primarily the sale of active pharmaceutical ingredients (API) to third parties, certain contract manufacturing services and an out-licensing platform offering a portfolio of products to other pharmaceutical companies through its affiliate Medis.
Employees
32,008
Date Price Change Volume
26-08-07 US$35.36 +1.58% 4,271,884
26-08-06 US$34.81 +0.26% 4,132,286
26-08-05 US$34.72 +0.84% 4,963,166
26-08-04 US$34.43 -0.09% 4,924,515
26-08-03 US$34.46 -1.57% 6,208,661
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
12
Last Close Price
35.36USD
Average target price
41.20USD
Spread / Average Target
+16.52%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TEVA Stock